Fig. 2From: Curcumin-Loaded Nanoparticles with Low-Intensity Focused Ultrasound-Induced Phase Transformation as Tumor-Targeted and pH-Sensitive Theranostic Nanoplatform of Ovarian CancerDrug cumulative release of FA-FCP in PBS (pH = 5.0/7.4) at 37 °C with or without LIFU after 3 h. **p < 0.01, compared with the other groupsBack to article page